JP Morgan Chase
RDHL

JP Morgan Chase’s Redhill Biopharma RDHL Stock Holding History

JP Morgan Chase’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$4 – 7631
2024
Q2 		– Hold
0
– – – 7255
2024
Q1 		– Hold
0
– – – 7268
2023
Q4 		– Hold
0
– – – 7408
2023
Q3 		– Sell
-3
Closed -$78 – 7377
2023
Q2 		$93 Buy
+3
New +$173 ﹤0.01% 6700
2023
Q1 		– Hold
0
– – – 7138
2022
Q4 		– Sell
-3
Closed -$1.3K – 6915
2022
Q3 		$1K Buy
3
+1
+50% +$871 ﹤0.01% 6362
2022
Q2 		$2K Sell
2
-4
-67% -$5.49K ﹤0.01% 6293
2022
Q1 		$15K Buy
6
+1
+20% +$2.37K ﹤0.01% 6130
2021
Q4 		$12K Sell
5
-41
-89% -$164K ﹤0.01% 6307
2021
Q3 		$209K Buy
46
+44
+2,200% +$298K ﹤0.01% 5209
2021
Q2 		$13K Sell
2
-57
-97% -$393K ﹤0.01% 6003
2021
Q1 		$434K Buy
+59
New +$495K ﹤0.01% 4756
2020
Q4 		– Hold
0
– – – 5877
2019
Q2 		– Sell
-1
Closed -$4K – 5963
2019
Q1 		$4K Buy
+1
New +$7.91K ﹤0.01% 5630
2018
Q4 		– Sell
-74
Closed -$652K – 5892
2018
Q3 		$652K Buy
74
+28
+61% +$228K ﹤0.01% 4152
2018
Q2 		$390K Buy
+46
New +$293K ﹤0.01% 4285
2018
Q1 		– Sell
-1
Closed -$4K – 5588
2017
Q4 		$4K Sell
1
-4
-80% -$26.9K ﹤0.01% 5336
2017
Q3 		$55K Buy
+5
New +$44.5K ﹤0.01% 4450

Other funds holding RDHL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

JP Morgan Chase's RDHL Position: Q3 2024 in Review

JP Morgan Chase held its Redhill Biopharma (RDHL) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7631.

JP Morgan Chase first reported a position in RDHL in Q3 2017 and has held it in 13 quarters since. The position peaked at $652K in Q3 2018. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

  • JP Morgan Chase held 0 shares of Redhill Biopharma worth $0 as of Q3 2024.
  • JP Morgan Chase left its Redhill Biopharma share count unchanged in Q3 2024.
  • Redhill Biopharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2024, its #7631 holding.
  • JP Morgan Chase first reported a position in Redhill Biopharma in Q3 2017 and has held it in 13 quarters since.
  • JP Morgan Chase's Redhill Biopharma position peaked at $652K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.